U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06894524) titled 'Retrospective Clinical Validation of HepatoPredict' on March 18.
Brief Summary: HepatoPredict is an innovative prognostic tool to support hepatologists, hepatobiliary surgeons and multidisciplinary teams in deciding on the best therapeutical approach for a patient with Hepatocellular Carcinoma, the most common type of primary liver cancer. HepatoPredict is a laboratory test that analyses a molecular signature from a small tumour sample and combines this information with details from imaging tests, such as the number of nodules and their size. Using a computational model, HepatoPredict determines whether a patient is likely to remai...